- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 2.88 Å
- Oligo State
- hetero-2-3-mer
- Ligands
- 10 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.2: 4 residues within 4Å:- Chain C: N.708, L.913, Q.917, Q.1062
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:L.913
NAG-NAG-BMA.6: 3 residues within 4Å:- Chain C: N.792, S.794, Q.795
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.7: 4 residues within 4Å:- Chain D: N.708, L.913, Q.917, Q.1062
1 PLIP interactions:1 interactions with chain D- Hydrophobic interactions: D:L.913
NAG-NAG-BMA.11: 3 residues within 4Å:- Chain D: N.792, S.794, Q.795
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.12: 4 residues within 4Å:- Chain E: N.708, L.913, Q.917, Q.1062
1 PLIP interactions:1 interactions with chain E- Hydrophobic interactions: E:L.913
NAG-NAG-BMA.16: 3 residues within 4Å:- Chain E: N.792, S.794, Q.795
No protein-ligand interaction detected (PLIP)- 26 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.17: 4 residues within 4Å:- Chain A: N.35, T.37, V.321, Q.322
Ligand excluded by PLIPNAG.18: 4 residues within 4Å:- Chain A: N.414, E.415, I.418, W.576
Ligand excluded by PLIPNAG.19: 2 residues within 4Å:- Chain A: V.298, N.304
Ligand excluded by PLIPNAG.20: 4 residues within 4Å:- Chain A: Q.63, N.85, S.88, V.89
Ligand excluded by PLIPNAG.21: 4 residues within 4Å:- Chain B: N.35, T.37, N.40, Q.322
Ligand excluded by PLIPNAG.22: 5 residues within 4Å:- Chain B: F.267, N.414, E.415, I.418, W.576
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain C: N.607, Q.635
- Chain E: L.840
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain C: S.699, N.700
- Chain E: Y.787
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain C: A.697, E.1063, N.1065
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain C: N.323, P.570, Q.571
Ligand excluded by PLIPNAG.27: 4 residues within 4Å:- Chain C: T.102, T.103, N.226, T.228
Ligand excluded by PLIPNAG.28: 1 residues within 4Å:- Chain C: N.27
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain C: L.840
- Chain D: N.607, Q.635
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain C: Y.787
- Chain D: S.699, N.700
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain D: A.697, E.1063, K.1064, N.1065
Ligand excluded by PLIPNAG.32: 4 residues within 4Å:- Chain D: P.322, N.323, P.570, Q.571
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain D: R.338, N.346, T.348
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain D: H.331, N.335
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain D: T.102, N.226, T.228
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain D: N.27
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain D: L.840
- Chain E: N.607, Q.635
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain D: Y.787
- Chain E: N.700
Ligand excluded by PLIPNAG.39: 1 residues within 4Å:- Chain E: N.1065
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain E: N.323, P.570, Q.571
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain E: T.102, N.226, T.228
Ligand excluded by PLIPNAG.42: 1 residues within 4Å:- Chain E: N.27
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Feng, Z., Structure of SARS-CoV-2 KP.3.1.1 Spike Protein. To Be Published
- Release Date
- 2025-05-28
- Peptides
- Processed angiotensin-converting enzyme 2: AB
Spike glycoprotein: CDE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
CC
ED
FE
G
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 2.88 Å
- Oligo State
- hetero-2-3-mer
- Ligands
- 10 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 26 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Feng, Z., Structure of SARS-CoV-2 KP.3.1.1 Spike Protein. To Be Published
- Release Date
- 2025-05-28
- Peptides
- Processed angiotensin-converting enzyme 2: AB
Spike glycoprotein: CDE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
CC
ED
FE
G